Research into Bordetella pertussis toxin continues, with a focus on understanding its precise mechanisms of action and developing more effective vaccines. Current challenges include the declining efficacy of existing vaccines over time and the emergence of vaccine-resistant strains. Innovative approaches in vaccine development, such as acellular vaccines and novel adjuvants, are being explored to address these issues.
